L. Heimans

753 total citations
29 papers, 538 citations indexed

About

L. Heimans is a scholar working on Rheumatology, Hematology and Genetics. According to data from OpenAlex, L. Heimans has authored 29 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Rheumatology, 8 papers in Hematology and 7 papers in Genetics. Recurrent topics in L. Heimans's work include Rheumatoid Arthritis Research and Therapies (22 papers), Autoimmune and Inflammatory Disorders Research (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). L. Heimans is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (22 papers), Autoimmune and Inflammatory Disorders Research (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). L. Heimans collaborates with scholars based in Netherlands, Sweden and United Kingdom. L. Heimans's co-authors include T. Huizinga, Cornelia F Allaart, Bernard Grillet, P. B. J. de Sonnaville, André J. Peeters, J.H.L.M. van Groenendael, M. van Oosterhout, Robbert J Goekoop, Karen Visser and H. K. Ronday and has published in prestigious journals such as Annals of the Rheumatic Diseases, European Journal of Cancer and Lara D. Veeken.

In The Last Decade

L. Heimans

26 papers receiving 529 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. Heimans Netherlands	13	446	156	98	81	66	29	538
P. B. J. de Sonnaville Netherlands	14	525 1.2×	195 1.3×	123 1.3×	90 1.1×	88 1.3×	18	599
R. Pappu United States	5	235 0.5×	111 0.7×	91 0.9×	131 1.6×	97 1.5×	7	447
M A van de Laar Netherlands	7	809 1.8×	315 2.0×	126 1.3×	120 1.5×	83 1.3×	11	918
Annmarie Wesley Sweden	5	370 0.8×	99 0.6×	60 0.6×	78 1.0×	56 0.8×	5	488
Greet Esselens Belgium	6	287 0.6×	80 0.5×	44 0.4×	60 0.7×	50 0.8×	7	428
Lars Erik Kristensen Denmark	11	397 0.9×	122 0.8×	91 0.9×	66 0.8×	180 2.7×	17	525
Harri Blåfield Finland	10	592 1.3×	243 1.6×	125 1.3×	108 1.3×	73 1.1×	12	672
Maria D. Mjaavatten Norway	13	292 0.7×	84 0.5×	52 0.5×	42 0.5×	44 0.7×	28	389
Gary Kunkel United States	10	318 0.7×	202 1.3×	74 0.8×	54 0.7×	111 1.7×	22	552
Marina Scolnik Argentina	14	305 0.7×	75 0.5×	31 0.3×	73 0.9×	157 2.4×	43	485

Countries citing papers authored by L. Heimans

Since Specialization

Citations

This map shows the geographic impact of L. Heimans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Heimans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Heimans more than expected).

Fields of papers citing papers by L. Heimans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Heimans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Heimans. The network helps show where L. Heimans may publish in the future.

Co-authorship network of co-authors of L. Heimans

This figure shows the co-authorship network connecting the top 25 collaborators of L. Heimans. A scholar is included among the top collaborators of L. Heimans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Heimans. L. Heimans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Laan, P. van der, Winan J. van Houdt, Hester van Boven, et al.. (2025). The role of whole-genome sequencing for guiding systemic therapy in patients with soft tissue sarcoma. ESMO Open. 10(6). 105287–105287. 1 indexed citations

Fiocco, Marta, Jan F. Ubbels, Lukas B. Been, et al.. (2025). Pandemic driven preoperative moderate hypofractionated radiotherapy for soft tissue sarcomas. European Journal of Cancer. 217. 115234–115234. 1 indexed citations

Fiocco, Marta, Aisha Miah, Ilse de Pree, et al.. (2025). Long-term survival of participants in the PASART-1 and PASART-2 trials of neo-adjuvant pazopanib and radiotherapy in soft tissue sarcoma. Acta Oncologica. 64. 69–77.

Reijers, Sophie J. M., Anke Kuijpers, L. Heimans, et al.. (2024). Neoadjuvant chemotherapy for radiation associated angiosarcoma (RAAS) of the breast: A retrospective single center study. The Breast. 78. 103825–103825. 2 indexed citations

Heimans, L., Sytske Anne Bergstra, Robbert J Goekoop, et al.. (2017). Clinical and radiological outcomes of 5-year drug-free remission-steered treatment in patients with early arthritis: IMPROVED study. Annals of the Rheumatic Diseases. 77(1). 111–118. 52 indexed citations

Heimans, L., Yvonne P M Goekoop-Ruiterman, J.H.L.M. van Groenendael, et al.. (2016). Two-year results of disease activity score (DAS)-remission-steered treatment strategies aiming at drug-free remission in early arthritis patients (the IMPROVED-study). Arthritis Research & Therapy. 18(1). 23–23. 36 indexed citations

Verheul, Marije K., L. Heimans, Yvonne P M Goekoop-Ruiterman, et al.. (2016). Predictive factors of radiological progression after 2 years of remission-steered treatment in early arthritis patients: a post hoc analysis of the IMPROVED study. RMD Open. 2(1). e000172–e000172. 12 indexed citations

Heimans, L., Karen Visser, Anne A. Schouffoer, et al.. (2015). Determinants of reaching drug-free remission in patients with early rheumatoid or undifferentiated arthritis after one year of remission-steered treatment. Lara D. Veeken. 54(8). 1380–1384. 11 indexed citations

Heimans, L., Marije K. Verheul, Anne A. Schouffoer, et al.. (2014). Radiological Outcomes after Two Years of Remission Steered Treatment in Early Arthritis Patients. Data Archiving and Networked Services (DANS). 66. 1 indexed citations

10.

Heimans, L., H. K. Ronday, P. B. J. de Sonnaville, et al.. (2014). Can we prevent rapid radiological progression in patients with early rheumatoid arthritis?. Clinical Rheumatology. 34(1). 163–166. 7 indexed citations

11.

Heimans, L., K. Visser, Robbert J Goekoop, et al.. (2013). Four-month metacarpal bone mineral density loss predicts radiological joint damage progression after 1 year in patients with early rheumatoid arthritis: exploratory analyses from the IMPROVED study. Annals of the Rheumatic Diseases. 74(2). 341–346. 23 indexed citations

12.

Heimans, L., K. Visser, Robbert J Goekoop, et al.. (2013). A two-step treatment strategy trial in patients with early arthritis aimed at achieving remission: the IMPROVED study. Annals of the Rheumatic Diseases. 73(7). 1356–1361. 83 indexed citations

13.

Heimans, L., K. Visser, H. K. Ronday, et al.. (2013). The relationship between disease activity and depressivesymptoms severity and optimism—results from the IMPROVED study. Clinical Rheumatology. 32(12). 1751–1757. 10 indexed citations

14.

Heimans, L., et al.. (2013). Drug therapy in undifferentiated arthritis: a systematic literature review. Annals of the Rheumatic Diseases. 72(9). 1436–1444. 27 indexed citations

15.

Heimans, L., K. Visser, Y P M Goekoop-Ruiterman, et al.. (2013). FRI0094 Outcomes of two years of remission steered treatment in early arthritis patients. Annals of the Rheumatic Diseases. 72. A401–A401. 1 indexed citations

16.

Aken, Jill van, L. Heimans, Karen Visser, et al.. (2013). Five-year outcomes of probable rheumatoid arthritis treated with methotrexate or placebo during the first year (the PROMPT study). Annals of the Rheumatic Diseases. 73(2). 396–400. 33 indexed citations

17.

Heimans, L., K. Visser, Anne A. Schouffoer, et al.. (2013). OP0182 Drug Free Remission After One Year of Treatment in Patients with Early Rheumatoid Arthritis: Also Possible for ACPA Positive Patients?. Annals of the Rheumatic Diseases. 72. A114–A114. 2 indexed citations

18.

Visser, Karen, L. Heimans, H. K. Ronday, et al.. (2012). Remission induction therapy with methotrexate and prednisone in patients with early rheumatoid and undifferentiated arthritis (the IMPROVED study). Annals of the Rheumatic Diseases. 71(9). 1472–1477. 78 indexed citations

19.

Heimans, L., K. Visser, H. K. Ronday, et al.. (2011). Remission Induction Therapy with Methotrexate and Prednisone in Patients with Early Rheumatoid and Undifferentiated Arthritis.. Arthritis & Rheumatism. 63(10). 4 indexed citations

20.

Heimans, L., Maries van den Broek, Linda Dirven, et al.. (2011). Body Mass Index Is Associated with Decreased Response to Initial and Delayed Treatment with Dose Escalated Infliximab in Patients with Recent Onset Rheumatoid Arthritis. Data Archiving and Networked Services (DANS). 63(10). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact